Legend Biotech

On #WorldLungCancerDay, we reaffirm our dedication to advancing CAR-T #CellTherapy research for those battling small cell lung cancer (#SCLC). Learn more about the cutting-edge CAR-T cell research our scientists are conducting to address this unmet need: https://lnkd.in/g5qhSpYW

In honor of #NationalInternDay, we want to recognize the 30 university students who joined us this summer.  Over the last several weeks, they have immersed themselves in every aspect of our business by participating in weekly Lunch and Learn sessions featuring different departments.  Check out photos from our HR session, where they completed mock interviews and got to walk away with some practical knowledge and tips.    #WeAreLegend #Internship  

At Legend Biotech, #CellTherapy research is the foundation of our work.  Watch for insights from Wang (Kenneth) Zhang, Executive Director of Research Platform, as he discusses unanswered questions in the cell therapy field and how they will shape the future of research. #WeAreLegend

As a token of appreciation to our LEGENDary team, we had a visit from an ice cream truck at our global headquarters in Somerset, NJ. It was the perfect way to cool down and catch up with colleagues on this hot summer day.     #WeAreLegend  

#LegendNews: Legend Biotech will host a webcast to share 2024 second-quarter financial results on August 9. Register to join the live webcast here: https://lnkd.in/g8gFDUqv #CellTherapy

Our LEGENDs in Ghent, Belgium, embody the phrase “one Legend” and often observe special occasions as a team. Recently, they celebrated the summer solstice together. Team building is a favorite pastime at Legend. Would you like to join our growing team? Click here to see our current openings. https://lnkd.in/e-rXFgQq #WeAreLegend

#LegendNews: As we continue our pursuit to transform patients’ lives, we are pleased to announce a positive interim analysis from our Phase 3 #MultipleMyeloma study.    Read the topline results: https://bit.ly/4cNaxHt   #CellTherapy 

Explore our state-of-the-art CAR-T Cell processing facility at Tech Lane in Ghent, Belgium.    As the demand for our #CellTherapy increases, we are scaling up our capabilities and streamlining our manufacturing processes to expand capacity and meet patients’ needs.     Learn more about our approach: https://lnkd.in/eNs5VmNJ     #Biotech #CART  

In an interview with Pharmaceutical Executive, our CEO, Ying Huang, discusses the promising potential of CAR-T therapies as they move up the #MultipleMyeloma treatment paradigm.     Click here to read the article and learn more about our latest data presented at #ASCO24: https://lnkd.in/eer3kCSx

Legend Biotech was featured in Scientific American, where we discussed the success of CAR-T cell therapies in transforming the treatment paradigm for #MultipleMyeloma.  Learn how we are racing to treat more patients faster: https://lnkd.in/eC_iEmMc #CellTherapy #CART